Conatus Pharmaceuticals Inc. Business Operations Contracts & Agreements

14 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Notice of Termination and Letter Agreement, dated September 18, 2023, by and between the Company and Joyce Reyes
Termination Agreements
Conatus Pharmaceuticals Inc.
Biotechnology
2023
Notice of Termination and Letter Agreement, dated September 18, 2023, by and between the Company and Alfred P. Spada
Termination Agreements
Conatus Pharmaceuticals Inc.
Biotechnology
2023
Notice of Termination and Letter Agreement, dated September 18, 2023 by and between the Company and Steven J. Mento
Termination Agreements
Conatus Pharmaceuticals Inc.
Biotechnology
2023
Letter Agreement by and between Histogen, Inc. and Allergan Sales, LLC, dated March 18, 2022
Sales Agreements
Conatus Pharmaceuticals Inc.
Biotechnology
2022
Collaborative Development and Commercialization Agreement, dated as of October 26, 2020, by and between the Company and Amerimmune LLC
Development Agreements
Conatus Pharmaceuticals Inc.
Biotechnology
CA
2020
Amended and Restated Supply Agreement, dated December 16, 2013, by and between Histogen Inc. and Suneva Medical, Inc
Supply Agreements
Conatus Pharmaceuticals Inc.
Biotechnology
CA
2020
Termination of Stockholder Agreements, dated January 28, 2020, by and among Histogen Inc., Lordship Ventures Histogen Holdings LLC, Pineworld Capital Limited, Gail K. Naughton,...
Termination Agreements
Conatus Pharmaceuticals Inc.
Biotechnology
DE
2020
Conversion, Termination and Release Agreement, dated August 10, 2016, by and among Histogen Inc., Jonathan Jackson, Lordship Ventures LLC and Lordship Ventures Histogen Holdings...
Termination Agreements
Conatus Pharmaceuticals Inc.
Biotechnology
DE
2020
Settlement, Release and Termination Agreement, dated April 5, 2019, by and among Histogen Inc., PUR Biologics, LLC, Wylde, LLC, Christopher Wiggins and Ryan Fernan
Termination Agreements
Conatus Pharmaceuticals Inc.
Biotechnology
CA
2020
Form of Indemnification Agreement, between Histogen Inc. and its officers and directors
Indemnification Agreements
Conatus Pharmaceuticals Inc.
Biotechnology
DE
2020
Amendment to Option, Collaboration and License Agreement, dated September 30, 2019, by and between Novartis Pharma AG and Conatus
Collaboration Agreements
Conatus Pharmaceuticals Inc.
Biotechnology
NY
2019
At Market Issuance Sales Agreement, dated August 2, 2018, between the Registrant and Stifel, Nicolaus & Company, Incorporated
Sales Agreements
Conatus Pharmaceuticals Inc.
Biotechnology
NY
2018
FORM OF INDEMNIFICATION AGREEMENT
Indemnification Agreements
Conatus Pharmaceuticals Inc.
Biotechnology
DE
2013
DISTRIBUTION AGREEMENT FOR EMRICASAN ASSETS by and between CONATUS PHARMACEUTICALS INC. and IDUN PHARMACEUTICALS, INC. January 10, 2013 DISTRIBUTION AGREEMENT
Distribution Agreements
Conatus Pharmaceuticals Inc.
Biotechnology
CA
2013